Latest Australian Securities News

SEQ Hospitality Group has formally withdrawn its off-market takeover bid for Eumundi Group following shareholder and court approval of a competing scheme of arrangement. This move effectively ends the takeover offer and confirms the scheme as the path forward for Eumundi shareholders.

Eumundi Group Limited’s shares have been suspended from ASX trading following Federal Court approval of its acquisition by SEQ Hospitality Group Pty Ltd, marking a pivotal step in the company’s transition.

Eumundi Group's scheme of arrangement has been legally approved, paving the way for SEQ Hospitality Group to acquire all shares at $1.62 each. Trading of Eumundi shares on the ASX is suspended effective immediately, with payment scheduled for mid-February.

Betashares Mrtn Currie Real Income Fund (RINC) units were suspended from trading on the ASX on 4 February 2025, following a prior announcement in December 2024. This suspension marks a significant operational shift for the managed fund.

The Federal Court of Australia has approved SEQ Hospitality Group’s acquisition of Eumundi Group, setting the stage for a $1.62 per share cash payout to shareholders and imminent suspension of Eumundi’s ASX trading.

Sigma Healthcare has secured Federal Court approval for its acquisition of Chemist Warehouse, marking a pivotal step in reshaping Australia's pharmaceutical retail landscape.

AustChina Holdings Limited has had its trading suspension lifted following the disclosure of a material acquisition, signaling a pivotal moment for the investment firm.

Viridis Mining and Minerals Limited has been reinstated to ASX quotation following a capital raising announcement, ending its trading suspension and signaling renewed investor confidence.

Mako Gold Limited’s securities have been suspended from ASX trading following Aurum Resources’ dispatch of compulsory acquisition notices, signaling a pivotal ownership transition.

Sigma Healthcare has received Federal Court approval for its acquisition of Chemist Warehouse, marking a pivotal step in its strategic expansion. The scheme is set to become legally effective on February 4, 2025, with implementation expected by February 12.

Dateline Resources Limited’s shares were suspended from ASX trading on 3 February 2025 due to a delayed periodic report, raising questions about compliance and future market activity.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.